{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T01:02:27Z","timestamp":1779670947272,"version":"3.53.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-026-00958-3","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T18:14:11Z","timestamp":1776104051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Progranulin genetic variant rs5848 displays ancestry-specific associations with Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Benjamin E.","family":"Life","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick I.","family":"Navarro-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Fornes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyeth W.","family":"Wasserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keegan","family":"Korthauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair R.","family":"Leavitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"Pt 11","key":"958_CR1","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1093\/brain\/awl271","volume":"129","author":"IR Mackenzie","year":"2006","unstructured":"Mackenzie IR, et al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain. 2006;129(Pt 11):3081\u201390.","journal-title":"Brain"},{"issue":"20","key":"958_CR2","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1093\/hmg\/ddl241","volume":"15","author":"J Gass","year":"2006","unstructured":"Gass J, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet. 2006;15(20):2988\u20133001.","journal-title":"Hum Mol Genet"},{"issue":"7105","key":"958_CR3","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature05016","volume":"442","author":"M Baker","year":"2006","unstructured":"Baker M, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442(7105):916\u20139.","journal-title":"Nature"},{"issue":"6","key":"958_CR4","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.ajhg.2012.04.021","volume":"90","author":"KR Smith","year":"2012","unstructured":"Smith KR, et al. Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. Am J Hum Genet. 2012;90(6):1102\u20137.","journal-title":"Am J Hum Genet"},{"issue":"23","key":"958_CR5","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1093\/hmg\/ddn257","volume":"17","author":"R Rademakers","year":"2008","unstructured":"Rademakers R, et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet. 2008;17(23):3631\u201342.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"958_CR6","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s00415-014-7630-2","volume":"262","author":"Y Chen","year":"2015","unstructured":"Chen Y, et al. Association of progranulin polymorphism rs5848 with neurodegenerative diseases: a meta-analysis. J Neurol. 2015;262(4):814\u201322.","journal-title":"J Neurol"},{"issue":"10","key":"958_CR7","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/nm.3672","volume":"20","author":"SS Minami","year":"2014","unstructured":"Minami SS, et al. Progranulin protects against amyloid beta deposition and toxicity in Alzheimer\u2019s disease mouse models. Nat Med. 2014;20(10):1157\u201364.","journal-title":"Nat Med"},{"issue":"5","key":"958_CR8","doi-asserted-by":"publisher","first-page":"e97032","DOI":"10.1371\/journal.pone.0097032","volume":"9","author":"JM Van Kampen","year":"2014","unstructured":"Van Kampen JM, Baranowski D, Kay DG. Progranulin gene delivery protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease. PLoS ONE. 2014;9(5):e97032.","journal-title":"PLoS ONE"},{"issue":"10","key":"958_CR9","doi-asserted-by":"publisher","first-page":"e13368","DOI":"10.1371\/journal.pone.0013368","volume":"5","author":"AS Laird","year":"2010","unstructured":"Laird AS, et al. Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy. PLoS ONE. 2010;5(10):e13368.","journal-title":"PLoS ONE"},{"key":"958_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1750-1326-5-41","volume":"5","author":"BP Chitramuthu","year":"2010","unstructured":"Chitramuthu BP, et al. Progranulin modulates zebrafish motoneuron development in vivo and rescues truncation defects associated with knockdown of Survival motor neuron 1. Mol Neurodegener. 2010;5:41.","journal-title":"Mol Neurodegener"},{"issue":"1\u20132","key":"958_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jns.2010.10.009","volume":"300","author":"GY Hsiung","year":"2011","unstructured":"Hsiung GY, et al. rs5848 polymorphism and serum progranulin level. J Neurol Sci. 2011;300(1\u20132):28\u201332.","journal-title":"J Neurol Sci"},{"issue":"1","key":"958_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3233\/JAD-2012-120946","volume":"33","author":"A Kamalainen","year":"2013","unstructured":"Kamalainen A, et al. GRN variant rs5848 reduces plasma and brain levels of granulin in Alzheimer\u2019s disease patients. J Alzheimers Dis. 2013;33(1):23\u20137.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"958_CR13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/hmg\/ddx413","volume":"27","author":"A Tonjes","year":"2018","unstructured":"Tonjes A, et al. Genome-wide meta-analysis identifies novel determinants of circulating serum progranulin. Hum Mol Genet. 2018;27(3):546\u201358.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"958_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13195-024-01420-z","volume":"16","author":"IJ Swift","year":"2024","unstructured":"Swift IJ, et al. A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors. Alzheimers Res Ther. 2024;16(1):66.","journal-title":"Alzheimers Res Ther"},{"issue":"1\u20133","key":"958_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000289231","volume":"7","author":"DW Dickson","year":"2010","unstructured":"Dickson DW, Baker M, Rademakers R. Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly. Neurodegener Dis. 2010;7(1\u20133):170\u20134.","journal-title":"Neurodegener Dis"},{"issue":"5","key":"958_CR16","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/ajmg.b.30889","volume":"150B","author":"J Viswanathan","year":"2009","unstructured":"Viswanathan J, et al. An association study between granulin gene polymorphisms and Alzheimer\u2019s disease in Finnish population. Am J Med Genet Part B: Neuropsychiatric Genet. 2009;150B(5):747\u201350.","journal-title":"Am J Med Genet Part B: Neuropsychiatric Genet"},{"issue":"4","key":"958_CR17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000322538","volume":"8","author":"MJ Lee","year":"2011","unstructured":"Lee MJ, et al. rs5848 variant of progranulin gene is a risk of Alzheimer\u2019s disease in the Taiwanese population. Neurodegener Dis. 2011;8(4):216\u201320.","journal-title":"Neurodegener Dis"},{"issue":"2","key":"958_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.gene.2014.03.041","volume":"542","author":"J Sheng","year":"2014","unstructured":"Sheng J, et al. Progranulin polymorphism rs5848 is associated with increased risk of Alzheimer\u2019s disease. Gene. 2014;542(2):141\u20135.","journal-title":"Gene"},{"issue":"2","key":"958_CR19","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s12035-016-9698-4","volume":"54","author":"H-M Xu","year":"2017","unstructured":"Xu H-M, et al. PGRN Is Associated with Late-Onset Alzheimer\u2019s Disease: a Case\u2013Control Replication Study and Meta-analysis. Mol Neurobiol. 2017;54(2):1187\u201395.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"958_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-023-00633-4","volume":"18","author":"M Kang","year":"2023","unstructured":"Kang M, et al. A genome-wide search for pleiotropy in more than 100,000 harmonized longitudinal cognitive domain scores. Mol Neurodegener. 2023;18(1):40.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"958_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54(4):412\u201336.","journal-title":"Nat Genet"},{"issue":"10","key":"958_CR22","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3109\/00207454.2015.1086345","volume":"126","author":"Y Chen","year":"2016","unstructured":"Chen Y, et al. Association analysis of the GRN rs5848 and MAPT rs242557 polymorphisms in Parkinson\u2019s disease and multiple system atrophy: a large-scale population-based study and meta-analysis. Int J Neurosci. 2016;126(10):947\u201354.","journal-title":"Int J Neurosci"},{"issue":"2","key":"958_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/bpa.12773","volume":"30","author":"SRK Hokkanen","year":"2020","unstructured":"Hokkanen SRK, et al. Putative risk alleles for LATE-NC with hippocampal sclerosis in population-representative autopsy cohorts. Brain Pathol. 2020;30(2):364\u201372.","journal-title":"Brain Pathol"},{"key":"958_CR24","doi-asserted-by":"publisher","first-page":"105880","DOI":"10.1016\/j.nbd.2022.105880","volume":"174","author":"Y Katsumata","year":"2022","unstructured":"Katsumata Y, et al. Multiple gene variants linked to Alzheimer\u2019s-type clinical dementia via GWAS are also associated with non-Alzheimer\u2019s neuropathologic entities. Neurobiol Dis. 2022;174:105880.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"958_CR25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s40478-021-01250-2","volume":"9","author":"AJ Dugan","year":"2021","unstructured":"Dugan AJ, et al. Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study. Acta Neuropathol Commun. 2021;9(1):152.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"958_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00401-021-02383-3","volume":"143","author":"MT Uemura","year":"2022","unstructured":"Uemura MT, et al. Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease. Acta Neuropathol. 2022;143(1):15\u201331.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"958_CR27","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1038\/s41588-024-01939-9","volume":"56","author":"LMP Shade","year":"2024","unstructured":"Shade LMP, et al. GWAS of multiple neuropathology endophenotypes identifies new risk loci and provides insights into the genetic risk of dementia. Nat Genet. 2024;56(11):2407\u201321.","journal-title":"Nat Genet"},{"issue":"3","key":"958_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00401-014-1302-2","volume":"128","author":"ME Murray","year":"2014","unstructured":"Murray ME, et al. Differential clinicopathologic and genetic features of late-onset amnestic dementias. Acta Neuropathol. 2014;128(3):411\u201321.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"958_CR29","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/WAD.0b013e31820f8f50","volume":"25","author":"WC Pao","year":"2011","unstructured":"Pao WC, et al. Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically. Alzheimer Dis Assoc Disord. 2011;25(4):364\u20138.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"958_CR30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3233\/JAD-2009-1170","volume":"18","author":"C Fenoglio","year":"2009","unstructured":"Fenoglio C, et al. Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer\u2019s disease. J Alzheimers Dis. 2009;18(3):603\u201312.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"958_CR31","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/j.1468-1331.2009.02621.x","volume":"16","author":"B Jasinska-Myga","year":"2009","unstructured":"Jasinska-Myga B, et al. GRN 3\u2032UTR\u2009+\u200978 C\u2009>\u2009T is not associated with risk for Parkinson\u2019s disease. Eur J Neurol. 2009;16(8):909\u201311.","journal-title":"Eur J Neurol"},{"issue":"10","key":"958_CR32","doi-asserted-by":"publisher","first-page":"e7494","DOI":"10.1371\/journal.pone.0007494","volume":"4","author":"J Sim\u00f3n-S\u00e1nchez","year":"2009","unstructured":"Sim\u00f3n-S\u00e1nchez J, et al. Variation at GRN 3\u2032-UTR rs5848 Is Not Associated with a Risk of Frontotemporal Lobar Degeneration in Dutch Population. PLoS ONE. 2009;4(10):e7494.","journal-title":"PLoS ONE"},{"issue":"4","key":"958_CR33","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.neurobiolaging.2009.04.009","volume":"32","author":"S Rollinson","year":"2011","unstructured":"Rollinson S, et al. No association of PGRN 3\u2032UTR rs5848 in frontotemporal lobar degeneration. Neurobiol Aging. 2011;32(4):754\u20135.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"958_CR34","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1111\/ene.12090","volume":"20","author":"I Mateo","year":"2013","unstructured":"Mateo I, et al. Reduced serum progranulin level might be associated with Parkinson\u2019s disease risk. Eur J Neurol. 2013;20(12):1571\u20133.","journal-title":"Eur J Neurol"},{"issue":"1","key":"958_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/NEN.0000000000000151","volume":"74","author":"PT Nelson","year":"2015","unstructured":"Nelson PT, et al. Reassessment of risk genotypes (GRN, TMEM106B, and ABCC9 variants) associated with hippocampal sclerosis of aging pathology. J Neuropathol Exp Neurol. 2015;74(1):75\u201384.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"958_CR36","doi-asserted-by":"publisher","first-page":"e0261007","DOI":"10.1371\/journal.pone.0261007","volume":"17","author":"NY Jung","year":"2022","unstructured":"Jung NY, et al. Serum progranulin is not associated with rs5848 polymorphism in Korean patients with neurodegenerative diseases. PLoS ONE. 2022;17(1):e0261007.","journal-title":"PLoS ONE"},{"issue":"9","key":"958_CR37","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/jnen\/nlad059","volume":"82","author":"Y Katsumata","year":"2023","unstructured":"Katsumata Y, et al. LATE-NC risk alleles (in TMEM106B, GRN, and ABCC9 genes) among persons with African ancestry. J Neuropathol Exp Neurol. 2023;82(9):760\u20138.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"958_CR38","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41588-020-00766-y","volume":"53","author":"EG Atkinson","year":"2021","unstructured":"Atkinson EG, et al. Tractor uses local ancestry to enable the inclusion of admixed individuals in GWAS and to boost power. Nat Genet. 2021;53(2):195\u2013204.","journal-title":"Nat Genet"},{"issue":"7818","key":"958_CR39","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41586-020-2493-4","volume":"583","author":"JE Moore","year":"2020","unstructured":"Moore JE, et al. Expanded encyclopaedias of DNA elements in the human and mouse genomes. Nature. 2020;583(7818):699\u2013710.","journal-title":"Nature"},{"key":"958_CR40","doi-asserted-by":"crossref","unstructured":"Fishilevich S et al. GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database (Oxford), 2017. 2017.","DOI":"10.1093\/database\/bax028"},{"issue":"1","key":"958_CR41","doi-asserted-by":"publisher","first-page":"180141","DOI":"10.1038\/sdata.2018.141","volume":"5","author":"O Fornes","year":"2018","unstructured":"Fornes O, et al. MANTA2, update of the Mongo database for the analysis of transcription factor binding site alterations. Sci Data. 2018;5(1):180141.","journal-title":"Sci Data"},{"key":"958_CR42","first-page":"pD87","volume":"48D1","author":"O Fornes","year":"2020","unstructured":"Fornes O, et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2020;48D1:pD87\u2013D92.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"958_CR43","doi-asserted-by":"publisher","first-page":"e70237","DOI":"10.1002\/alz.70237","volume":"21","author":"YY Leung","year":"2025","unstructured":"Leung YY, et al. Alzheimer\u2019s Disease Sequencing Project release 4 whole genome sequencing dataset. Alzheimers Dement. 2025;21(5):e70237.","journal-title":"Alzheimers Dement"},{"key":"958_CR44","doi-asserted-by":"crossref","unstructured":"Kampourakis K, Peterson EL. The racist origins, racialist connotations, and purity assumptions of the concept of admixture in human evolutionary genetics. Genetics, 2023. 223(3).","DOI":"10.1093\/genetics\/iyad002"},{"key":"958_CR45","doi-asserted-by":"crossref","unstructured":"Kampourakis K. Ancestry Reimagined: Dismantling the Myth of Genetic Ethnicities. Oxford University Press; 2023.","DOI":"10.1093\/oso\/9780197656341.001.0001"},{"issue":"4","key":"958_CR46","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ygeno.2018.05.004","volume":"111","author":"AC Naj","year":"2019","unstructured":"Naj AC, et al. Quality control and integration of genotypes from two calling pipelines for whole genome sequence data in the Alzheimer\u2019s disease sequencing project. Genomics. 2019;111(4):808\u201318.","journal-title":"Genomics"},{"issue":"6","key":"958_CR47","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gr.229102","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent WJ, et al. The human genome browser at UCSC. Genome Res. 2002;12(6):996\u20131006.","journal-title":"Genome Res"},{"issue":"D1","key":"958_CR48","doi-asserted-by":"publisher","first-page":"D316","DOI":"10.1093\/nar\/gkab996","volume":"50","author":"F Hammal","year":"2021","unstructured":"Hammal F, et al. ReMap 2022: a database of Human, Mouse, Drosophila and Arabidopsis regulatory regions from an integrative analysis of DNA-binding sequencing experiments. Nucleic Acids Res. 2021;50(D1):D316\u201325.","journal-title":"Nucleic Acids Res"},{"key":"958_CR49","doi-asserted-by":"crossref","unstructured":"Danecek P et al. Twelve years of SAMtools and BCFtools. GigaScience, 2021. 10(2).","DOI":"10.1093\/gigascience\/giab008"},{"issue":"1","key":"958_CR50","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1038\/s41467-019-13225-y","volume":"10","author":"O Delaneau","year":"2019","unstructured":"Delaneau O, et al. Accurate, scalable and integrative haplotype estimation. Nat Commun. 2019;10(1):5436.","journal-title":"Nat Commun"},{"issue":"18","key":"958_CR51","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1016\/j.cell.2022.08.004","volume":"185","author":"M Byrska-Bishop","year":"2022","unstructured":"Byrska-Bishop M, et al. High-coverage whole-genome sequencing of the expanded 1000 Genomes Project cohort including 602 trios. Cell. 2022;185(18):3426\u2013e344019.","journal-title":"Cell"},{"issue":"2","key":"958_CR52","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ajhg.2013.06.020","volume":"93","author":"BK Maples","year":"2013","unstructured":"Maples BK, et al. RFMix: a discriminative modeling approach for rapid and robust local-ancestry inference. Am J Hum Genet. 2013;93(2):278\u201388.","journal-title":"Am J Hum Genet"},{"issue":"24","key":"958_CR53","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1093\/bioinformatics\/btz567","volume":"35","author":"SM Gogarten","year":"2019","unstructured":"Gogarten SM, et al. Genetic association testing using the GENESIS R\/Bioconductor package. Bioinformatics. 2019;35(24):5346\u20138.","journal-title":"Bioinformatics"},{"issue":"24","key":"958_CR54","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1093\/bioinformatics\/bts610","volume":"28","author":"SM Gogarten","year":"2012","unstructured":"Gogarten SM, et al. GWASTools: an R\/Bioconductor package for quality control and analysis of genome-wide association studies. Bioinformatics. 2012;28(24):3329\u201331.","journal-title":"Bioinformatics"},{"issue":"24","key":"958_CR55","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1093\/bioinformatics\/bts606","volume":"28","author":"X Zheng","year":"2012","unstructured":"Zheng X, et al. A high-performance computing toolset for relatedness and principal component analysis of SNP data. Bioinformatics. 2012;28(24):3326\u20138.","journal-title":"Bioinformatics"},{"issue":"12","key":"958_CR56","doi-asserted-by":"publisher","first-page":"e1011242","DOI":"10.1371\/journal.pgen.1011242","volume":"20","author":"KE Grinde","year":"2024","unstructured":"Grinde KE, et al. Adjusting for principal components can induce collider bias in genome-wide association studies. PLoS Genet. 2024;20(12):e1011242.","journal-title":"PLoS Genet"},{"key":"958_CR57","doi-asserted-by":"publisher","first-page":"105314","DOI":"10.1016\/j.nbd.2021.105314","volume":"153","author":"TL Petkau","year":"2021","unstructured":"Petkau TL, et al. Human progranulin-expressing mice as a novel tool for the development of progranulin-modulating therapeutics. Neurobiol Dis. 2021;153:105314.","journal-title":"Neurobiol Dis"},{"key":"958_CR58","doi-asserted-by":"publisher","first-page":"106138","DOI":"10.1016\/j.nbd.2023.106138","volume":"182","author":"B Life","year":"2023","unstructured":"Life B, et al. FTD-associated behavioural and transcriptomic abnormalities in \u2018humanized\u2019 progranulin-deficient mice: A novel model for progranulin-associated FTD. Neurobiol Dis. 2023;182:106138.","journal-title":"Neurobiol Dis"},{"key":"958_CR59","first-page":"1221","volume":"95","author":"JN Hellwege","year":"2017","unstructured":"Hellwege JN, et al. Population Stratification in Genetic Association Studies. Curr Protoc Hum Genet. 2017;95:1221\u201312223.","journal-title":"Curr Protoc Hum Genet"},{"key":"958_CR60","doi-asserted-by":"crossref","unstructured":"Xu W et al. The FAM171A2 gene is a key regulator of progranulin expression and modifies the risk of multiple neurodegenerative diseases. Sci Adv, 2020. 6(43).","DOI":"10.1126\/sciadv.abb3063"},{"issue":"7","key":"958_CR61","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.tins.2014.04.003","volume":"37","author":"TL Petkau","year":"2014","unstructured":"Petkau TL, Leavitt BR. Progranulin in neurodegenerative disease. Trends Neurosci. 2014;37(7):388\u201398.","journal-title":"Trends Neurosci"},{"issue":"5","key":"958_CR62","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/acn3.560","volume":"5","author":"YA Cooper","year":"2018","unstructured":"Cooper YA, et al. Progranulin levels in blood in Alzheimer\u2019s disease and mild cognitive impairment. Ann Clin Transl Neurol. 2018;5(5):616\u201329.","journal-title":"Ann Clin Transl Neurol"},{"issue":"10","key":"958_CR63","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.bbagen.2009.07.010","volume":"1790","author":"T Flatt","year":"2009","unstructured":"Flatt T, Schmidt PS. Integrating evolutionary and molecular genetics of aging. Biochim Biophys Acta. 2009;1790(10):951\u201362.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"958_CR64","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.ajhg.2022.05.014","volume":"109","author":"RA Patel","year":"2022","unstructured":"Patel RA, et al. Genetic interactions drive heterogeneity in causal variant effect sizes for gene expression and complex traits. Am J Hum Genet. 2022;109(7):1286\u201397.","journal-title":"Am J Hum Genet"},{"issue":"12","key":"958_CR65","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.jalz.2019.07.016","volume":"15","author":"EE Blue","year":"2019","unstructured":"Blue EE, et al. Local ancestry at APOE modifies Alzheimer\u2019s disease risk in Caribbean Hispanics. Alzheimers Dement. 2019;15(12):1524\u201332.","journal-title":"Alzheimers Dement"},{"issue":"11","key":"958_CR66","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1038\/s41380-022-01729-x","volume":"27","author":"MS Naslavsky","year":"2022","unstructured":"Naslavsky MS, et al. Global and local ancestry modulate APOE association with Alzheimer\u2019s neuropathology and cognitive outcomes in an admixed sample. Mol Psychiatry. 2022;27(11):4800\u20138.","journal-title":"Mol Psychiatry"},{"issue":"16","key":"958_CR67","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278(16):1349\u201356.","journal-title":"JAMA"},{"issue":"12","key":"958_CR68","doi-asserted-by":"publisher","first-page":"e1007791","DOI":"10.1371\/journal.pgen.1007791","volume":"14","author":"F Rajabli","year":"2018","unstructured":"Rajabli F, et al. Ancestral origin of ApoE \u03b54 Alzheimer disease risk in Puerto Rican and African American populations. PLoS Genet. 2018;14(12):e1007791.","journal-title":"PLoS Genet"},{"issue":"1","key":"958_CR69","doi-asserted-by":"publisher","first-page":"e12211","DOI":"10.1002\/trc2.12211","volume":"7","author":"SP Dickson","year":"2021","unstructured":"Dickson SP, et al. GenoRisk: A polygenic risk score for Alzheimer\u2019s disease. Alzheimers Dement (N Y). 2021;7(1):e12211.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"2","key":"958_CR70","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41591-021-01672-4","volume":"28","author":"S Fatumo","year":"2022","unstructured":"Fatumo S, et al. A roadmap to increase diversity in genomic studies. Nat Med. 2022;28(2):243\u201350.","journal-title":"Nat Med"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-026-00958-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-026-00958-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-026-00958-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:02:56Z","timestamp":1779667376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40246-026-00958-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["958"],"URL":"https:\/\/doi.org\/10.1186\/s40246-026-00958-3","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"O.F. is employed by Roche. All other authors report no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"91"}}